Epidemiology
Session Posters
Real-time PCR assays identify
transmitted drug-resistant HIV-1 previously undetected by conventional nucleotide
sequencing
JA Johnson
Estimating resistance in drug
experienced patients in the UK
D Pillay
Prevalence
of multiple-class antiretroviral drug resistance in HIV-1-treated patients
F Brun-Vézinet
Predicted
phenotypic resistance in routine clinical samples between 1998 and 2003
AR Rinehart
Changes
in prevalence of NRTI resistance associated mutations among clinical isolates
from 1999–2003
H Faruki
Large
scale cluster analysis of HIV-1 protease mutations in a clinical database
R Kagan
The changing prevalence of HIV-1
protease (PR) and reverse transcriptase (RT) polymorphisms in primary HIV infection
(PHI), chronic-naive, and following exposure to antiretroviral therapy (ART)
C Loveday
HIV drug resistance and treatment
failure: contrasting mortality and viral load endpoints
PR Harrigan
A screening algorithm for surveillance
of antiretroviral drug resistance among individuals newly diagnosed with HIV
in the US
D Bennett
Validation of molecular indicators
of resistance transmission (MIRTs) for epidemiological studies of drug resistance
transmission in HIV
D van de Vijver
The calculated genetic barrier
for drug resistance mutations in six different non-B subtypes and two CRFs in
a large European dataset is largely similar to subtype B
DAMC van de Vijver
Nucleotide and amino acid polymorphisms at drug resistance sites in non-B subtype
HIV-1 variants
D Turner
HIV drug resistance among HIV+
injection drug users: risk behaviour and patients’ beliefs on the transmissibility
of HIV
M Kozal
Natural history of transmitted
drug resistant and wild-type infections and superinfection in the Montreal Primary
HIV-1 Infection (PHI) cohort
BG Brenner
Slower serological evolution in
primary HIV-1 drug resistance
HM Truong
Determination of transmission
rate differences of various HIV-1 drug-resistant mutations with meta-analysis
J-P Routy
Clusters and trends in primary
resistance in San Francisco, 2001–2003
RM Grant
HIV drug resistance among foreign-born
persons newly diagnosed with HIV in the US
DE Bennett
Surveillance of HIV antiretroviral
drug resistance and subtypes in newly diagnosed HIV-infected patients in Spain
in 2003
L Ruiz
Prevalence
of reduced drug susceptibility in treatment-naive patients in the UK
DT Dunn
The prevalence of drug resistance
in a population of individuals testing positive for HIV infection in Canada
from 2000–2003
T Gleeson
Transmission of antiretroviral
drug resistant HIV strains between 1996 and 2003 in Victoria, Australia, and
their subsequent evolution in untreated individuals
T Middleton
Genotypic HIV-drug resistance
among newly diagnosed, never treated persons in Mexico
LE Soto-Ramírez
Prevalence of mutations associated with antiretroviral drug resistance (ARVDR)
in a cohort of treated individuals in four US cities
AJ Smith
Analysis of PTAP duplications
in the gag p6 region of subtype C HIV-1
SH Eshleman
Nelfinavir resistance in HIV-1
subtype B and G infected patients: evidence for different pathways and novel
mutations associated with failure of nelfinavir based regimens
R Camacho
Temporal characterization of
frequency of drug-resistance associated mutations in the HIV-1 protease and
reverse transcriptase
F Ceccherini-Silberstein